ArchiMed-backed NAMSA acquires American Preclinical Services
NAMSA, which is backed by ArchiMed, has acquired American Preclinical Services, a provider of medical device and pharmaceutical testing.
NAMSA, which is backed by ArchiMed, has acquired American Preclinical Services, a provider of medical device and pharmaceutical testing.
Copyright PEI Media
Not for publication, email or dissemination